raxofelast
|
|
raxofelast |
|
|
raxofelast |
|
|
5-acetyloxy-2,3-dihydro-4,6,7-trimethyl-2-benzofuranacetic acid |
|
|
A10 drugs used in diabetes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Antioxidant/radical scavenger |
|
|
|
|
|
Phase II |
|
|
Europe |
|
|
|
|
|
|
|
|
license |
|
|
dr. Stefano Ceccarelli Regulatory Affairs & Licensing Manager Biomedica Foscama SpA via Morolense, 87 03013 Ferentino (FR), Italy tel. +39 0775 8021 fax: +39 0775 223363 |
|
|
http:// |
|
|
There are currently no items in this folder.
Last modified
2005-09-08 20:30